nodes	percent_of_prediction	percent_of_DWPC	metapath
Medrysone—Ulcerative keratitis—Erlotinib—lung cancer	0.108	0.121	CcSEcCtD
Medrysone—Nerve injury—Paclitaxel—lung cancer	0.0726	0.0814	CcSEcCtD
Medrysone—Keratitis—Gefitinib—lung cancer	0.0703	0.0788	CcSEcCtD
Medrysone—Keratitis—Erlotinib—lung cancer	0.042	0.0471	CcSEcCtD
Medrysone—Visual disturbance—Crizotinib—lung cancer	0.0384	0.0431	CcSEcCtD
Medrysone—Conjunctivitis—Pemetrexed—lung cancer	0.0249	0.028	CcSEcCtD
Medrysone—Conjunctivitis—Gefitinib—lung cancer	0.0248	0.0278	CcSEcCtD
Medrysone—Keratitis—Paclitaxel—lung cancer	0.0244	0.0274	CcSEcCtD
Medrysone—Visual impairment—Crizotinib—lung cancer	0.0243	0.0272	CcSEcCtD
Medrysone—Hydrocortisone—ANXA1—lung cancer	0.0224	0.208	CrCbGaD
Medrysone—Impaired healing—Methotrexate—lung cancer	0.0224	0.0251	CcSEcCtD
Medrysone—Vision blurred—Crizotinib—lung cancer	0.0207	0.0232	CcSEcCtD
Medrysone—Testosterone Propionate—UGT1A1—lung cancer	0.0194	0.18	CrCbGaD
Medrysone—Eye irritation—Paclitaxel—lung cancer	0.0186	0.0208	CcSEcCtD
Medrysone—Viral infection—Paclitaxel—lung cancer	0.0175	0.0197	CcSEcCtD
Medrysone—Eye irritation—Docetaxel—lung cancer	0.0157	0.0176	CcSEcCtD
Medrysone—Visual disturbance—Irinotecan—lung cancer	0.0149	0.0167	CcSEcCtD
Medrysone—Conjunctivitis—Erlotinib—lung cancer	0.0148	0.0166	CcSEcCtD
Medrysone—Pain—Pemetrexed—lung cancer	0.014	0.0157	CcSEcCtD
Medrysone—Pain—Gefitinib—lung cancer	0.0139	0.0156	CcSEcCtD
Medrysone—Keratitis—Doxorubicin—lung cancer	0.0129	0.0145	CcSEcCtD
Medrysone—Visual disturbance—Paclitaxel—lung cancer	0.0121	0.0136	CcSEcCtD
Medrysone—Hypersensitivity—Pemetrexed—lung cancer	0.0121	0.0135	CcSEcCtD
Medrysone—Hypersensitivity—Gefitinib—lung cancer	0.012	0.0134	CcSEcCtD
Medrysone—Stinging—Doxorubicin—lung cancer	0.0103	0.0116	CcSEcCtD
Medrysone—Visual disturbance—Docetaxel—lung cancer	0.0103	0.0115	CcSEcCtD
Medrysone—Hypersensitivity—Teniposide—lung cancer	0.00977	0.0109	CcSEcCtD
Medrysone—Conjunctivitis—Cisplatin—lung cancer	0.00959	0.0108	CcSEcCtD
Medrysone—Visual impairment—Irinotecan—lung cancer	0.0094	0.0105	CcSEcCtD
Medrysone—Viral infection—Doxorubicin—lung cancer	0.00928	0.0104	CcSEcCtD
Medrysone—Prednisolone—CYP2A6—lung cancer	0.009	0.0834	CrCbGaD
Medrysone—Pain—Vinblastine—lung cancer	0.00865	0.0097	CcSEcCtD
Medrysone—Conjunctivitis—Paclitaxel—lung cancer	0.00862	0.00966	CcSEcCtD
Medrysone—Visual impairment—Cisplatin—lung cancer	0.00854	0.00957	CcSEcCtD
Medrysone—Pain—Topotecan—lung cancer	0.0084	0.00942	CcSEcCtD
Medrysone—Pain—Erlotinib—lung cancer	0.00831	0.00932	CcSEcCtD
Medrysone—Visual impairment—Paclitaxel—lung cancer	0.00767	0.0086	CcSEcCtD
Medrysone—Hypersensitivity—Vinblastine—lung cancer	0.00745	0.00835	CcSEcCtD
Medrysone—Visual disturbance—Methotrexate—lung cancer	0.00741	0.00831	CcSEcCtD
Medrysone—Conjunctivitis—Docetaxel—lung cancer	0.0073	0.00819	CcSEcCtD
Medrysone—Vision blurred—Cisplatin—lung cancer	0.00727	0.00815	CcSEcCtD
Medrysone—Hypersensitivity—Topotecan—lung cancer	0.00724	0.00811	CcSEcCtD
Medrysone—Pain—Vinorelbine—lung cancer	0.00719	0.00806	CcSEcCtD
Medrysone—Vision blurred—Paclitaxel—lung cancer	0.00653	0.00732	CcSEcCtD
Medrysone—Visual impairment—Docetaxel—lung cancer	0.0065	0.00729	CcSEcCtD
Medrysone—Drospirenone—PTGS2—lung cancer	0.00637	0.059	CrCbGaD
Medrysone—Megestrol acetate—ABCB1—lung cancer	0.00621	0.0575	CrCbGaD
Medrysone—Hypersensitivity—Vinorelbine—lung cancer	0.00619	0.00694	CcSEcCtD
Medrysone—Hydrocortisone—ABCG2—lung cancer	0.00616	0.057	CrCbGaD
Medrysone—Pain—Irinotecan—lung cancer	0.00593	0.00664	CcSEcCtD
Medrysone—Pain—Gemcitabine—lung cancer	0.00577	0.00647	CcSEcCtD
Medrysone—Progesterone—CYP2A6—lung cancer	0.00561	0.0519	CrCbGaD
Medrysone—Pain—Cisplatin—lung cancer	0.00538	0.00603	CcSEcCtD
Medrysone—Conjunctivitis—Methotrexate—lung cancer	0.00526	0.0059	CcSEcCtD
Medrysone—Hypersensitivity—Irinotecan—lung cancer	0.00511	0.00572	CcSEcCtD
Medrysone—Pain—Etoposide—lung cancer	0.00493	0.00553	CcSEcCtD
Medrysone—Pain—Paclitaxel—lung cancer	0.00483	0.00542	CcSEcCtD
Medrysone—Methylprednisolone—ABCB1—lung cancer	0.00475	0.044	CrCbGaD
Medrysone—Testosterone—ABCG2—lung cancer	0.00474	0.0439	CrCbGaD
Medrysone—Visual impairment—Methotrexate—lung cancer	0.00468	0.00525	CcSEcCtD
Medrysone—Hypersensitivity—Cisplatin—lung cancer	0.00464	0.0052	CcSEcCtD
Medrysone—Conjunctivitis—Doxorubicin—lung cancer	0.00456	0.00511	CcSEcCtD
Medrysone—Hypersensitivity—Etoposide—lung cancer	0.00425	0.00476	CcSEcCtD
Medrysone—Hypersensitivity—Paclitaxel—lung cancer	0.00416	0.00467	CcSEcCtD
Medrysone—Pain—Docetaxel—lung cancer	0.0041	0.00459	CcSEcCtD
Medrysone—Visual impairment—Doxorubicin—lung cancer	0.00406	0.00455	CcSEcCtD
Medrysone—Vision blurred—Methotrexate—lung cancer	0.00399	0.00447	CcSEcCtD
Medrysone—Progesterone—CYP1A1—lung cancer	0.00393	0.0364	CrCbGaD
Medrysone—Testosterone—CYP1A1—lung cancer	0.00371	0.0344	CrCbGaD
Medrysone—Methyltestosterone—ALB—lung cancer	0.00357	0.033	CrCbGaD
Medrysone—Hypersensitivity—Docetaxel—lung cancer	0.00353	0.00396	CcSEcCtD
Medrysone—Vision blurred—Doxorubicin—lung cancer	0.00345	0.00387	CcSEcCtD
Medrysone—Prednisolone—ABCB1—lung cancer	0.00335	0.031	CrCbGaD
Medrysone—Pain—Methotrexate—lung cancer	0.00295	0.00331	CcSEcCtD
Medrysone—Hydrocortisone—ABCB1—lung cancer	0.00256	0.0237	CrCbGaD
Medrysone—Pain—Doxorubicin—lung cancer	0.00256	0.00287	CcSEcCtD
Medrysone—Hypersensitivity—Methotrexate—lung cancer	0.00254	0.00285	CcSEcCtD
Medrysone—Hypersensitivity—Doxorubicin—lung cancer	0.0022	0.00247	CcSEcCtD
Medrysone—Progesterone—ABCB1—lung cancer	0.00209	0.0193	CrCbGaD
Medrysone—Testosterone—ALB—lung cancer	0.00207	0.0192	CrCbGaD
Medrysone—Testosterone—ABCB1—lung cancer	0.00197	0.0183	CrCbGaD
